These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23540573)

  • 1. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
    French JD; Ghoussaini M; Edwards SL; Meyer KB; Michailidou K; Ahmed S; Khan S; Maranian MJ; O'Reilly M; Hillman KM; Betts JA; Carroll T; Bailey PJ; Dicks E; Beesley J; Tyrer J; Maia AT; Beck A; Knoblauch NW; Chen C; Kraft P; Barnes D; González-Neira A; Alonso MR; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Conroy D; Dennis J; Bolla MK; Wang Q; Hopper JL; Southey MC; Schmidt MK; Broeks A; Verhoef S; Cornelissen S; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Loehberg CR; Ekici AB; Beckmann MW; Peto J; dos Santos Silva I; Johnson N; Aitken Z; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias Perez JI; Benitez J; Anton-Culver H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Engel C; Brauch H; Hamann U; Justenhoven C; ; Aaltonen K; Heikkilä P; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Sueta A; Bogdanova NV; Antonenkova NN; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Peeters S; Smeets A; Floris G; Chang-Claude J; Rudolph A; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Sardella D; Couch FJ; Wang X; Pankratz VS; Lee A; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Ng CH; Vithana EN; Kristensen V; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Schoof N; Hooning MJ; Martens JW; Collée JM; Tilanus-Linthorst M; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Balasubramanian SP; Blot W; Signorello LB; Cai Q; Pharoah PD; Healey CS; Shah M; Pooley KA; Kang D; Yoo KY; Noh DY; Hartman M; Miao H; Sng JH; Sim X; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; McKay J; Toland AE; Ambrosone CB; Yannoukakos D; Godwin AK; Shen CY; Hsiung CN; Wu PE; Chen ST; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Nevanlinna H; Brown MA; Chenevix-Trench G; Easton DF; Dunning AM
    Am J Hum Genet; 2013 Apr; 92(4):489-503. PubMed ID: 23540573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.
    Betts JA; Moradi Marjaneh M; Al-Ejeh F; Lim YC; Shi W; Sivakumaran H; Tropée R; Patch AM; Clark MB; Bartonicek N; Wiegmans AP; Hillman KM; Kaufmann S; Bain AL; Gloss BS; Crawford J; Kazakoff S; Wani S; Wen SW; Day B; Möller A; Cloonan N; Pearson J; Brown MA; Mercer TR; Waddell N; Khanna KK; Dray E; Dinger ME; Edwards SL; French JD
    Am J Hum Genet; 2017 Aug; 101(2):255-266. PubMed ID: 28777932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.
    Day BW; Stringer BW; Spanevello MD; Charmsaz S; Jamieson PR; Ensbey KS; Carter JC; Cox JM; Ellis VJ; Brown CL; Walker DG; Inglis PL; Allan S; Reynolds BA; Lickliter JD; Boyd AW
    Neuro Oncol; 2011 Nov; 13(11):1202-12. PubMed ID: 21846680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
    Hsiang CH; Straus DS
    Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico identification and functional validation of allele-dependent AR enhancers.
    Garritano S; Romanel A; Ciribilli Y; Bisio A; Gavoci A; Inga A; Demichelis F
    Oncotarget; 2015 Mar; 6(7):4816-28. PubMed ID: 25693204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.
    Biancolella M; Fortini BK; Tring S; Plummer SJ; Mendoza-Fandino GA; Hartiala J; Hitchler MJ; Yan C; Schumacher FR; Conti DV; Edlund CK; Noushmehr H; Coetzee SG; Bresalier RS; Ahnen DJ; Barry EL; Berman BP; Rice JC; Coetzee GA; Casey G
    Hum Mol Genet; 2014 Apr; 23(8):2198-209. PubMed ID: 24256810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.
    Lanzino M; Sisci D; Morelli C; Garofalo C; Catalano S; Casaburi I; Capparelli C; Giordano C; Giordano F; Maggiolini M; Andò S
    Nucleic Acids Res; 2010 Sep; 38(16):5351-65. PubMed ID: 20421209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.
    Mauro L; Pellegrino M; Giordano F; Ricchio E; Rizza P; De Amicis F; Catalano S; Bonofiglio D; Panno ML; Andò S
    FASEB J; 2015 May; 29(5):2150-60. PubMed ID: 25657113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.
    Schödel J; Bardella C; Sciesielski LK; Brown JM; Pugh CW; Buckle V; Tomlinson IP; Ratcliffe PJ; Mole DR
    Nat Genet; 2012 Mar; 44(4):420-5, S1-2. PubMed ID: 22406644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.
    Yang C; Chen L; Li C; Lynch MC; Brisken C; Schmidt EV
    Mol Cell Biol; 2010 Jun; 30(12):3111-25. PubMed ID: 20404095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
    Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
    Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.
    Yue L; Li L; Liu F; Hu N; Zhang W; Bai X; Li Y; Zhang Y; Fu L; Zhang X; Ye L
    Carcinogenesis; 2013 Apr; 34(4):927-35. PubMed ID: 23291272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proto-oncogene JUN is a target of the heat shock transcription factor HSF1.
    Sawai M; Ishikawa Y; Ota A; Sakurai H
    FEBS J; 2013 Dec; 280(24):6672-80. PubMed ID: 24127737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer.
    Cheng CK; Chow LW; Loo WT; Chan TK; Chan V
    Cancer Res; 2005 Oct; 65(19):8646-54. PubMed ID: 16204032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.